文献速递重症综合管理与镇静镇痛

三磷酸腺苷释放是Toll样受体诱导单核/巨噬细胞活化、炎症小体信号、白细胞介素-1β产生及抗感染免疫应答所必需的

Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte/Macrophage Activation, Inflammasome Signaling, Interleukin-1β Production, and the Host Immune Response to Infection.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论体外与小鼠实验显示,Toll样受体激动后线粒体快速产生并释放三磷酸腺苷,阻断嘌呤能信号可抑制p38丝裂原活化蛋白激酶、caspase-1活化及白细胞介素-1β分泌;pannexin-1缺失小鼠盲肠结扎穿孔后不能活化单核细胞、不能产生白细胞介素-1β且不能有效清除细菌。

该研究采用人单核细胞与U937巨噬细胞体外实验,以及野生型C57BL/6与pannexin-1敲除小鼠的随机动物实验,探讨嘌呤能信号在Toll样受体诱导的单核/巨噬细胞活化与白细胞介素-1β产生中的作用。结果发现Toll样受体激动剂在数秒内触发线粒体三磷酸腺苷产生与释放;抑制线粒体、三磷酸腺苷释放或P2受体可阻断p38丝裂原活化蛋白激酶与caspase-1活化及白细胞介素-1β分泌。pannexin-1缺失小鼠在盲肠结扎穿孔后不能活化单核细胞、不能产生白细胞介素-1β,且不能有效清除细菌。作者认为嘌呤能信号在单核/巨噬细胞活化中有两个独立作用:经Toll样受体促进危险信号的初始识别,以及随后调控NLRP3炎症小体活化。

要点

  • Toll样受体激动剂在数秒内触发人单核细胞与U937巨噬细胞线粒体三磷酸腺苷产生及释放。
  • 抑制线粒体、三磷酸腺苷释放或P2受体,可阻断p38丝裂原活化蛋白激酶与caspase-1活化及白细胞介素-1β分泌。
  • pannexin-1敲除小鼠盲肠结扎穿孔后不能活化单核细胞、不能产生白细胞介素-1β,且不能有效清除细菌。
  • 作者认为嘌呤能信号既经Toll样受体促进危险信号初始识别,又调控NLRP3炎症小体活化。
  • 作者认为进一步解析这些机制可能为重症患者的免疫调节提供新治疗靶点。

适用人群与场景

  • 体外实验用人单核细胞与U937巨噬细胞;动物实验用野生型C57BL/6与pannexin-1敲除小鼠;细胞分离来自健康人类受试者。

研究设计与关键结果

  • 研究设计为体外人类细胞实验联合随机动物实验,地点为临床前学术研究实验室。
  • Toll样受体激动剂在数秒内触发线粒体三磷酸腺苷产生与三磷酸腺苷释放。
  • 抑制线粒体、三磷酸腺苷释放或P2受体,可阻断p38丝裂原活化蛋白激酶与caspase-1活化及白细胞介素-1β分泌。
  • pannexin-1敲除小鼠在盲肠结扎穿孔后不能活化单核细胞、不能产生白细胞介素-1β,且不能有效清除细菌。

证据类型、等级与局限

  • 证据类型:体外人类细胞实验与随机动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为嘌呤能信号在单核/巨噬细胞活化中有两个独立作用:经Toll样受体促进危险信号的初始识别,以及随后调控NLRP3炎症小体活化。
  • 作者认为进一步解析这些机制可能为重症患者的免疫调节提供新治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Monocytes and macrophages produce interleukin-1β by inflammasome activation which involves adenosine triphosphate release, pannexin-1 channels, and P2X7 receptors. However, interleukin-1β can also be produced in an inflammasome-independent fashion. Here we studied if this mechanism also involves adenosine triphosphate signaling and how it contributes to inflammasome activation.

DESIGN: In vitro studies with human cells and randomized animal experiments.

SETTING: Preclinical academic research laboratory.

SUBJECTS: Wild-type C57BL/6 and pannexin-1 knockout mice, healthy human subjects for cell isolation.

INTERVENTIONS: Human monocytes and U937 macrophages were treated with different inhibitors to study how purinergic signaling contributes to toll-like receptor-induced cell activation and interleukin-1β production. Wild-type and pannexin-1 knockout mice were subjected to cecal ligation and puncture to study the role of purinergic signaling in interleukin-1β production and host immune defense.

MEASUREMENTS AND MAIN RESULTS: Toll-like receptor agonists triggered mitochondrial adenosine triphosphate production and adenosine triphosphate release within seconds. Inhibition of mitochondria, adenosine triphosphate release, or P2 receptors blocked p38 mitogen-activated protein kinase and caspase-1 activation and interleukin-1β secretion. Mice lacking pannexin-1 failed to activate monocytes, to produce interleukin-1β, and to effectively clear bacteria following cecal ligation and puncture.

CONCLUSIONS: Purinergic signaling has two separate roles in monocyte/macrophage activation, namely to facilitate the initial detection of danger signals via toll-like receptors and subsequently to regulate nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 3 inflammasome activation. Further dissection of these mechanisms may reveal novel therapeutic targets for immunomodulation in critical care patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lee AH, Ledderose C, Li X, et al. Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte/Macrophage Activation, Inflammasome Signaling, Interleukin-1β Production, and the Host Immune Response to Infection. Crit Care Med. 2018. PMID: 30247270. doi:10.1097/CCM.0000000000003446

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。